Affiliation:
1. Department of Medical Biochemistry and Biophysics, University of Umeå, Sweden.
Abstract
Some or most of the turnover of lipoprotein lipase (LPL) occurs by dissociation from vascular endothelial sites in extrahepatic tissues and further degradation in the liver. Heparin greatly enhances this dissociation and delays but does not abolish uptake in the liver, raising the possibility that heparin could lead to accelerated catabolism of functional LPL. To investigate this, we determined time curves for heparin (anti-factor Xa activity) and for LPL and hepatic lipase after injection in rats of two doses of conventional unfractionated heparin (UFH) or low-molecular-weight heparin (LMWH). The high dose (250 U/kg) of both heparins resulted in similar initial levels of LPL activity in plasma, but at 30 minutes the activity with LMWH had declined by more than 80%, whereas with UFH it remained essentially unchanged during this time. In contrast, time curves for heparin activity in blood were similar for the two heparins. The low dose (50 U/kg) led to lower initial levels of LPL activity with LMWH in spite of slower elimination of heparin activity from the blood. These results agree with previous studies that indicate that LMWH has a similar ability as UFH to release LPL, but a lesser ability to delay its removal by the liver. Only slight differences were noted in the time curves for hepatic lipase with the two heparins. To assess the possible depletion of the lipases, we administered a second large dose of conventional heparin. One hour after the first injection, the second injection resulted in lower plasma LPL activities in all four groups.(ABSTRACT TRUNCATED AT 250 WORDS)
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cardiology and Cardiovascular Medicine
Reference24 articles.
1. Olivecrona T Bengtsson-Olivecrona G. Heparin and Upases. In: Lane D Lindahl U eds. Heparin. London England: Edward Arnold Publishers Ltd; 1989335-361.
2. Molecular modeling of protein-glycosaminoglycan interactions.
3. Holmer E. Low-molecular weight heparin. In: Lane D Lindahl U eds. Heparin. London England: Edward Arnold Publishers Ltd; 1989:575-595.
4. Release of LPL activity after intravenous injection of a low molecular weight heparin.
5. Lipolytic and anticoagulant activities of a low molecular weight fragment of heparin
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献